BridgeMD
New treatment option for Cardiometabolic Diseases
Official title Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
ClinicalTrials.gov ID: NCT07158697
What this study is testing
- What it's testing
- The goal of this study is to: 1. assess the feasibility, acceptability, and the preliminary effects of the health chat for empowerment-based lifestyle planning for CMM (HcELP\_CMM); 2.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or above；
- Diagnosed with cardiometabolic multimorbidity (CMM), which was defined as co-existing with two or more cardiometabolic diseases, including primary...
- Possessed a digital device installed with WeChat, as well as with an internet connection.
You likely can't join if
- Contraindications to exercise according to American College of Sports Medicine (ACSM), such as severe musculoskeletal disorders, severe...
- Diagnosis of psychiatric disease;
- Has impaired cognitive function as indicated by an Abbreviated Mental Test Score (AMTS) ≤6;
- Has impaired sensory or communication function which hider them participation in this program, such as hearing loss, vision loss, and unable to speak...
The study team makes the final eligibility decision.
Where it's taking place
- Suzhou, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suzhou, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.